AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.02), $0.04 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $48.56 million versus the consensus estimate of $48.66 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.